| Control group (n = 36) | Intervention group (n = 33) | Whole group (n = 69) |
---|---|---|---|
Age (mean, SD) | 82.8 (7.9) | 84.3 (6.2) | 83.5 (7.1) |
Female (%) | 61 | 76 | 68 |
MMSE (n = 56), median (25th–75th percentile) | 3.0 (1.0–7.0) | 6.0 (2.0–10.0) | 4.0 (1.0–9.5) |
Dementia diagnoses, n (%) | |||
 AD | 20 (55.6) | 18 (54.5) | 38 (55.0) |
 VD | 2 (5.6) | 2 (6.0) | 4 (6.0) |
 Mixed AD and VD | 0 | 0 | 0 |
 LBD | 1 (2.8) | 0 | 1 (1.5) |
 FTD | 0 | 0 | 0 |
 PD | 0 | 0 | 0 |
 Unknown dementia | 10 (27.8) | 11 (33.3) | 21 (30.5) |
 Other dementia | 1 (2.8) | 1 (3.0) | 2 (3.0) |
 No diagnosis* | 2 (5.6) | 1 (3.0) | 3 (4.0) |
NPI-NH total score (n = 69), median (25th–75th percentile) | 12.5 (5.5–42.5) | 24.0 (11.0–42.0) | 21.0 (6.0–42.0) |
ADL (n = 69) (mean, SD) | 18.4 (4.7) | 17.1 (5.1) | 17.8 (4.9) |
FAST (n = 67), median (25th–75th percentile) | 6.0 (6.0–7.0) | 6.0 (6.0–6.0) | 6.0 (6.0–6.0) |
CCI (n = 69), median (25th–75th percentile) | 1.0 (1.0–2.0) | 2.0 (1.0–2.0) | 1.0 (1.0–2.0) |
No. of drugs (mean, SD) | 6.7 (3.0) | 6.5 (2.7) | 6.7 (2.8) |
No. of psychotropic drugs¤, median (25th–75th percentile) | 3.0 (1.3–3.8) | 3.0 (2.0–4.0) | 3.0 (2.0–4.0) |
Any psychotropic, n (%) | 34 (94%) | 31 (94%) | 65 (94%) |
No. of sedatives§, median (25th–75th percentile) | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) |
Any sedatives, n (%) | 3 (8%) | 6 (18%) | 9 (13%) |